Pozzaet al
(1990) Electrophysiological characterization of a novel potent and orally
active NMDA receptor antagonist: CGP 37849 and its ethylester CGP 39551.
Eur.J.Pharmacol. 182 91. Fagget al (1990) CGP
37849 and CGP 39551: novel and potent competitive N-methyl-D-asparate receptor
antagonists with oral activity. Br.J.Pharmacol. 99 791. Loscher
and Honack (1991) Anticonvulsant and behavioural effects of two novel
competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP
39551, in the kindling model of epilepsy. Comparison with MK-801 and
carbamazepine. J.Pharmacol.Exp.Ther. 256 432.
Displays 26-fold and > 440-fold selectivity over kainate and NMDA receptors respectively. Neuro-protective; delays neuronal death in a global ischaemia model and cerebral infarction in a focal ischaemia model.